LGALS1 and melanoma: The amount of extracellular of galectin-1 is altered in a variety of cancer cell types [54,55,56], including melanoma [57,58], ovarian [59,60], lung [61], prostate [62,63], bladder [64], thyroid [65,66], pancreatic [67], head-neck [68], cervical [69], uterine [70], and colorectal cancers [71,72].